Home Report Store Active Implantable Devices Market

Active Implantable Devices Market By Product Type [Implantable Cardioverter Defibrillators (Transvenous ICDs and Subcutaneous ICDs), Neuromodulators (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Gastric Electrical Stimulators), Implantable Cardiac Pacemakers, Implantable Hearing Devices, Ventricular Assist Devices, Implantable Heart Monitors/Insertable Loop Recorders] - Global Forecast To 2022

Report ID:MRHC - 104113 Pages: 197 Dec-2017 Formats*: PDF Category: Healthcare Delivery: 2 to 4 Hours

The digital age is changing the nature of health care delivery and offering explosive growth for medical devices within built wireless technologies (including both implanted and wearable devices) to control bodily functions and to measure an array of physiological parameters. Implanted devices can control heart rhythms, monitor hypertension, provide functional electrical stimulation of nerves, operate as glaucoma sensors, and monitor bladder and cranial pressure. Many wireless medical devices communicate with nearby receivers that are connected to landline networks, cellular systems or broadband facilities that access the internet. Patients no longer need to be tethered to one spot by a tangle of cables, creating a safer workplace for medical professionals and a more comfortable environment for the patient with a reduced risk of infection. Wireless monitoring permits patients to thrive outside medical environments, reducing health care costs and enabling physicians to obtain vital information on a real-time basis without the need for office visits or hospital admissions.

The active implantable devices market is expected to grow at a CAGR of 6.7% from 2017 to 2022 to reach USD 24.02 billion by 2022. The rising need for faster, effective, and safer devices is growing rapidly, which is majorly fueling the growth of the market. In addition, major factors such as increasing burden of cardiovascular diseases, rising prevalence of neurological disorders, growing investment & funds to develop technologically advanced products, and expanded applications of neurostimulators are expected to drive the growth of this market. However, stringent regulations for approvals & rising product recalls, high cost of implants, and unfavorable reimbursement scenario restricts the growth of the market to some extent. Further, increasing pricing pressure on market players poses a great challenge for the growth of this market.

Click here to: Get Free Sample Pages of this Report

Active Implantable Devices Market, By Geography, 2017-2022

The report further gives an extensive outlook on the major product categories and their sub-segments with detailed analysis of key trends, drivers, and key players, along with the detailed market size & forecasts for each individual segment at both regional & country level. The global active implantable devices market is mainly segmented by product type into implantable cardioverter defibrillators, neuromodulation, implantable cardiac pacemakers, implantable hearing devices, ventricular assist devices, and implantable heart monitors/insertable loop recorders. Implantable cardioverter defibrillators held the largest share of active implantable devices in 2016, primarily due to rising adoption of ICDs for the prevention of sudden cardiac deaths (SCD) in patients at high risk for SCD with increasing incidence of cardiac arrest and atrial fibrillation, and growing burden of patients with high blood pressure. According to the National Institute of Health, it is estimated that about 40-50% of all cardiovascular deaths are sudden cardiac deaths (SCDs) and about 80% of these are caused by ventricular tachyarrhythmias. Moreover, about 6 million sudden cardiac deaths occur annually due to ventricular tachyarrhythmias.

The implantable cardioverter defibrillators (ICDs) market is further sub-segmented into transvenous ICDs and subcutaneous ICDs with transvenous ICDs accounting for the major share, owing to their wide availability & adoption worldwide, anti-tachycardia pacing feature, increasing prevalence of cardiovascular diseases, and growing demand of the implantable therapy. Transvenous implantable cardioverter defibrillator market is further segmented into biventricular ICDs/cardiac resynchronization therapy defibrillators (CRT-DS), dual-chamber ICDs, and single-chamber ICDs.

An exhaustive analysis of the geographical scenario of the industry for the five major geographies: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa are included in the geographical analysis section. These regions are further analyzed at a country level with the detailed qualitative and quantitative analysis. The geographical analysis provides detailed insights on the key trends of the industry in the listed regions & countries, identifying the demographic & economic impact, government & private investments, and regulatory scenario. The report identifies North America to be the largest market, followed by Europe, Asia-Pacific, Latin America and Middle East & Africa.

However, Asia-Pacific region is slated to register the fastest growth in the global active implantable devices market during the forecast period, primarily due to the increasing population living with various chronic diseases, changing lifestyles, and rising inclination towards fast food. In addition, rising public & private spending for the development of proper healthcare infrastructure, increasing aging population, rising focus of the key players to expand in emerging countries like China & India, and increasing affordability of the middle-class population in the region are further expected to indirectly support the growth of active implantable devices market in this region. The geographical analysis section also comments on the key market players shaping the growth of the industry in the respective countries.

The report also includes the competitive landscape based on extensive assessment of the key strategic developments adopted by the leading market participants in the industry over the past 3 years (2014-2017). The study has also incorporated the market share analysis of leading players and detailed profiles of top 11 market players across the value chain of the industry, including detailed financial performance, product offerings, and strategic growth initiatives of each player.

The report provides the market share analysis by key players for various segments such as active implantable cardiovascular devices, neuromodulation, and implantable hearing devices. As a whole the active implantable devices market is highly consolidated with the top three players namely Medtronic plc (Ireland), Abbott Laboratories (U.S.), and Boston Scientific Corporation (U.S.) together holding around three-fourth share of this market in 2016. The other key players in the global active implantable devices market are BIOTRONIK SE & Co. KG (Germany), and LivaNova PLC (U.K.), Cochlear Limited (Australia), MED-EL (Austria), Sonova Holding AG (Switzerland), William Demant Holding A/S (Denmark), and Nurotron Biotechnology Co., Ltd. (China).

Scope of the Report:

Market by Product:

Implantable Cardioverter Defibrillators
- Transvenous Implantable Cardioverter Defibrillators
  - Biventricular Implantable Cardioverter Defibrillators
  - Dual-Chamber Implantable Cardioverter Defibrillators
  - Single-Chamber Implantable Cardioverter Defibrillators
- Subcutaneous Implantable Cardioverter Defibrillators
Implantable Cardiac Pacemakers
Ventricular Assist Devices
Implantable Heart Monitors/Insertable Loop Recorders
Implantable hearing devices
Neurostimulators
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Sacral Nerve Stimulators
- Vagus Nerve Stimulators
- Gastric Electrical Stimulators

Market by Geography

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
Rest of World
- Latin America
- Middle East and Africa

Key questions answered in the report:

Increasing prevalence of cardiovascular diseases to drive the adoption of active implantable devices market

How does the penetration of implantable cardioverter defibrillators devices in medical devices industry differ from the penetration of neuromodulators devices?
Which are the high growth market segments in terms of product type, and regions/countries?

The North American active implantable devices market favors both larger and local manufacturers that compete in multiple segments

Who are the top competitors in this market and what strategies do they employ to gain shares?
What is driving the growth and which market segments have the most potential for revenue expansion over the forecast period?
What strategies should new companies looking to enter this market use to compete effectively?
What are the major drivers, restrains, and opportunities in the global active implantable devices market?
Who are the major players in various countries and what share of the market do they hold?
What are the geographical trends and high growth regions/ countries?

Recent new approvals, collaborations, partnerships, and agreements, new product launch, and expansions taken place in the active implantable devices space.

What companies have recently partnerships/collaborations/agreements and how will these unions affect the competitive landscape of the active implantable devices space?
Which companies have recently received approvals and how will these approvals promote a competitive advantage?
Who are the major players in the global active implantable devices market and what share of the market do they hold?
Who are the local emerging players in the global active implantable devices market and how do they compete with the global players?

Enquire

Check Discount

Related Tag: Medical Technologies Healthcare Active Imlantable Devices Market

Medical Technologies

Healthcare

1. Introduction
1.1. Market Ecosystem
1.2. Currency and Limitations
1.2.1. Currency
1.2.2. Limitations
1.3. Key Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation

3. Executive Summary

4. Market insights
  4.1. Introduction
  4.2. Drivers
4.2.1. Increasing Burden of Cardiovascular Diseases
4.2.2. Rising Prevalence of Neurological Disorders
4.2.3. Growing Investments and Funds to Develop Technologically Advanced Products
4.2.4. Expanded Applications of Neurostimulators
  4.3. Restraints
4.3.1. Stringent Regulation for Approvals & Rising Product Recalls
4.3.2. Issues Related to the Use of Implantable Medical Devices
4.3.3. High Cost of Implants and an Unfavorable Reimbursement Scenario
  4.4. Opportunities
4.4.1. Emerging Markets offer Significant Growth Opportunities
  4.5. Challenges
4.5.1. Increasing Pricing Pressure on Market Players
4.5.2. Lack of Skilled Professionals
  4.6. Regulatory Analysis
4.6.1. North America
4.6.2. Europe
4.6.3. Asia-Pacific
4.6.4. Rest of World
  4.7. Active Implantable Devices Market Share Analysis by Key Players
4.7.1. Active Implantable Cardiovascular Devices Market
4.7.2. Neurostimulators Market
4.7.3. Active Implantable Hearing Devices Market

5. Active Implantable Devices Market, by Product
  5.1. Introduction
  5.2. Implantable Cardioverter Defibrillator
5.2.1. Transvenous Implantable Cardioverter Defibrillator
5.2.1.1. Biventricular Implantable Cardioverter Defibrillator
5.2.1.2. Dual-Chamber Implantable Cardioverter Defibrillators
5.2.1.3. Single-Chamber Implantable Cardioverter Defibrillators
5.2.2. Subcutaneous Implantable Cardioverter Defibrillators
  5.3. Implantable Cardiac Pacemakers
  5.4. Ventricular Assist Devices
  5.5. Implantable Heart Monitors/insertable Loop Recorders
  5.6. Neurostimulators
5.6.1. Spinal Cord Stimulators
5.6.2. Deep Brain Stimulators
5.6.3. Sacral Nerve Stimulators
5.6.4. Vagus Nerve Stimulators
5.6.5. Gastric Electrical Stimulators
  5.7. Implantable Hearing Devices

6. Active Implantable Devices Market, by Geography
  6.1. Introduction
  6.2. North America
6.2.1. U.S.
6.2.2. Canada
  6.3. Europe
6.3.1. Germany
6.3.2. France
6.3.3. U.K.
6.3.4. Italy
6.3.5. Spain
6.3.6. RoE
  6.4. Asia-Pacific
6.4.1. Japan
6.4.2. China
6.4.3. India
6.4.4. RoAPAC
  6.5. RoW
6.5.1. Latin America
6.5.2. Middle East & Africa

7. Competetive Landscape
  7.1. Approvals
  7.2. New Product Launch
  7.3. Mergers & Acquistions
  7.4. Expansions
  7.5. Partnerships, Collaborations & Agreements

8. Company Profiles (Business Overview, Financials, Product Portfolio, Recent Developments)
  8.1. Medtronic Plc
  8.2. Boston Scientific Corporation
  8.3. BIOTRONIK SE & CO., KG
  8.4. LivaNova Plc
  8.5. William Demant Holding A/S
  8.6. Cochlear Ltd.
  8.7. Sonova Holding AG
  8.8. MED-EL
  8.9. Nurotron Biotechnology Co. Ltd.
  8.10. Nuvectra Corporation
  8.11. Abbott Laboratories

9. Appendix
9.1. Questionnaire
9.2. Available Customization

List of Tables

Table 1 Active Imlantable Devices Market Drivers: Impact Analysis (2017–2022)
Table 2 Deaths Attributed to Neurological Disorders as Percentage of total Deaths, 2005, 2015 and 2030
Table 3 Active Implantable Devices Market Restraints: Impact Analysis (2017–2022)
Table 4 Number of Cardiac Implants and total Recall Reports
Table 5 Global Active Implantable Medical Devices Market Size, by Product, 2015-2022 (USD Million)
Table 6 Global Active Implantable Devices Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 7 Global Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 8 Global Implantable Cardioverter Defibrillators Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 9 Global Transvenous ICDs Market Size, by Type, 2015-2022 (USD Million)
Table 10 Global Transvenous Implantable Cardioverter Defibrillators Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 11 Global Biventricular Implantable Cardioverter Defibrillators (ICDs) Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 12 Global Dual-Chamber Implantable Cardioverter Defibrillators Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 13 Global Single-Chamber Implantable Cardioverter Defibrillators Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 14 FDA Approved Subcutaneous ICDs
Table 15 Global Subcutaneous Implantable Cardioverter Defibrillators Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 16 Global Implantable Pacemaker Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 17 Global Ventricular Assisted Devices Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 18 Global Implantable Loop Recorder Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 19 Global Neurostimulators Market Size, by Type, 2015-2022 (USD Million)
Table 20 Global Neuromodulators Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 21 Global Spinal Cord Stimulators Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 22 Global Deep Brain Stimulators Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 23 Global Sacral Nerve Stimulators Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 24 Global Vagus Nerve Stimulators Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 25 Global Gastric Electric Stimulators Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 26 Global Implantable Hearing Devices Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 27 Global Active Implantable Devices Market Size, by Country, 2015-2022 (USD Million)
Table 28 North America: Active Implantable Devices Market Size, by Country, 2015-2022 (USD Million)
Table 29 North America: Active Implantable Devices Market Size, by Type, 2015-2022 (USD Million)
Table 30 North America: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 31 North America: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 32 North America: Neurostimulators Market Size, by Type, 2015-2022 (USD Million)
Table 33 Projections on total Number of Pateints (Aged 65 Years & Above) With Alzheimer’s Dementia in Americans, by State, 2017-2025 (in Thousands)
Table 34 U.S.: Active Implantable Devices Market Size, by Type, 2015-2022 (USD Million)
Table 35 U.S.: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 36 U.S.: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 37 U.S.: Neurostimulators Market Size, by Type, 2015-2022 (USD Million)
Table 38 Canada: Active Implantable Devices Market Size, by Type, 2015-2022 (USD Million)
Table 39 Canada: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 40 Canada: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 41 Canada: Neurostimulators Market Size, by Type, 2015-2022 (USD Million)
Table 43 Europe: Active Implantable Devices Market Size, by Country, 2015-2022 (USD Million)
Table 44 Europe: Active Implantable Devices Market Size, by Type, 2015-2022 (USD Million)
Table 45 Europe: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 46 Europe: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 47 Europe: Neurostimulators Market Size, by Type, 2015-2022 (USD Million)
Table 48 Germany: Active Implantable Devices Market Size, by Type, 2015-2022 (USD Million)
Table 49 Germany: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 50 Germany: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 51 Germany: Neurostimulators Market Size, by Type, 2015-2022 (USD Million)
Table 52 France: Active Implantable Devices Market Size, by Type, 2015-2022 (USD Million)
Table 53 France: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 54 France: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 55 France: Neurostimulators Market Size, by Type, 2015-2022 (USD Million)
Table 56 U.K.: Active Implantable Devices Market Size, by Type, 2015-2022 (USD Million)
Table 57 U.K.: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 58 U.K.: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 59 U.K.: Neurostimulators, by Type, 2015-2022 (USD Million)
Table 60 Italy: Active Implantable Devices Market Size, by Type, 2015-2022 (USD Million)
Table 61 Italy: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 62 Italy: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 63 Italy: Neurostimulators Market Size, by Type, 2015-2022 (USD Million)
Table 64 Spain: Active Implantable Devices Market Size, by Type, 2015-2022 (USD Million)
Table 65 Spain: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 66 Spain: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 67 Spain: Neurostimulators Market Size, by Type, 2015-2022 (USD Million)
Table 68 RoE: Active Implantable Devices Market Size, by Type, 2015-2022 (USD Million)
Table 69 RoE: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 70 RoE: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 71 RoE: Neurostimulators Market Size, by Type, 2015-2022 (USD Million)
Table 72 APAC: Active Implantable Devices Market Size, by Country, 2015-2022 (USD Million)
Table 73 APAC: Active Implantable Devices Market Size, by Type, 2015-2022 (USD Million)
Table 74 APAC: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 75 APAC: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 76 APAC: Neurostimulators Market Size, by Type, 2015-2022 (USD Million)
Table 77 Japan: Active Implantable Devices Market Size, by Type, 2015-2022 (USD Million)
Table 78 Japan: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 79 Japan: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 80 Japan: Neurostimulators Market Size, by Type, 2015-2022 (USD Million)
Table 81 China: Active Implantable Devices Market Size, by Type, 2015-2022 (USD Million)
Table 82 China: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 83 China: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 84 China: Neurostimulators Market Size, by Type, 2015-2022 (USD Million)
Table 85 India: Active Implantable Devices Market Size, by Type, 2015-2022 (USD Million)
Table 86 India: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 87 India: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 88 India: Neurostimulators Market Size, by Type, 2015-2022 (USD Million)
Table 89 RoAPAC: Active Implantable Devices Market Size, by Type, 2015-2022 (USD Million)
Table 90 RoAPAC: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 91 RoAPAC: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 92 RoAPAC: Neurostimulators Market Size, by Type, 2015-2022 (USD Million)
Table 93 RoW: Active Implantable Devices Market Size, by Country, 2015-2022 (USD Million)
Table 94 RoW: Active Implantable Devices Market Size, bytype, 2015-2022 (USD Million)
Table 95 RoW: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 96 RoW: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 97 RoW: Neurostimulators Market Size, by Type, 2015-2022 (USD Million)
Table 98 Latin America: Active Implantable Devices Market Size, by Type, 2015-2022 (USD Million)
Table 99 Latin America: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 100 Latin America: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 101 Latin America: Neurostimulators Market Size, by Type, 2015-2022 (USD Million)
Table 102 Middle East & Africa: Active Implantable Devices Market Size, by Type, 2015-2022 (USD Million)
Table 103 Middle East & Africa: Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 104 Middle East & Africa: Transvenous Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Table 105 Middle East & Africa: Neurostimulators Market Size, by Type, 2015-2022 (USD Million)
Table 106 Number of Developments by the Profiled Companies, 2014-2017
Table 107 Approvals
Table 108 New Product Launches
Table 109 Megers & Acquisitions
Table 110 Expansions
Table 111 Partnerships, Collaborations & Agreements

List of Figures

Figure 1 Research Process
Figure 2 Key Executives interviewed
Figure 3 Primary Research Techniques
Figure 4 Key Opportunities
Figure 5 Implantable Hearing Devices is the Fastest Growing Segment Among All Active Implantable Devices
Figure 6 Global Active Implantable Devices Market Size, by Type, 2017-2022 (USD Million)
Figure 7 Transvenuos ICDs Dominates the Overall Implantable Cardioverter Defibrillator Market
Figure 8 Biventricular ICDs Dominates in Transvenous Cardioverter Defibrillator Market
Figure 9 Global Active Implantable Devices Market Overview-2017-2022
Figure 10 Key Growth Strategies Adopted by Leading Players -2015-2017
Figure 11 Market Dynamics
Figure 12 Incidence of Cardiovascular Disease in Italy, by Sex, 2000-2015
Figure 13 Global Cardivascular Diseases Deaths by Type, 2015
Figure 14 Age of People With Alzheimer Dementia in the U.S., 2017
Figure 15 Percentage Distribution of Population Aged 65 and Over by Region, 2015-2050
Figure 16 Total Physician Shortage in the U.S., 2015-2030
Figure 17 Regulatory Approval Pathway in U.S.
Figure 18 Global Active Implantable Cardiovascular Devices Market Share, by Key Players, 2016
Figure 19 Global Neurostimulators Market Share, by Key Players, 2016
Figure 20 Global Implantable Hearing Devices Market Share, by Key Players, 2016
Figure 21 Global Active Implantable Devices Market Size, by Type, 2017-2022
Figure 22 Facts About Sudden Cardiac Arrest
Figure 23 Global Implantable Cardioverter Defibrillators Market Size, by Type, 2015-2022 (USD Million)
Figure 24 List of Fda Approved Transvenous ICDs
Figure 25 Percentage Breakdown of Death Due to CVD in U.S., 2014
Figure 26 Reimbursement Scenario for Pacemakers in the U.S.
Figure 27 Transplant Performed in the U.S., 2016
Figure 28 Global Neurostimulators Market Size, by Type, 2015-2022 (USD Million)
Figure 29 Obesity Fact, 2016
Figure 30 Facts & Figure About Hearing Loss in U.S.
Figure 31 Global Active Implantable Devices Market Size, by Region, 2017-2022 (USD Million)
Figure 32 Projected Number of Geriatric Population (Aged 65 Years & Above) in U.S., 2000-2030
Figure 33 Total Deaths by Disease Category in U.S.- 2015
Figure 34 Ageing Population in Canada
Figure 35 The Share of Death by Cause in European Males, 2016
Figure 36 The Share of Death by Cause in European Females, 2016
Figure 37 Total Number of Deaths From CVD, by Country, 2014-2020
Figure 38 Change in Population Structure in Germany, 1975-2015
Figure 39 Total Number of Death by Cause, 2014
Figure 40 Percentage of Population Aged 65 Years and Above (% of total), 2011-2015
Figure 41 Incidence of CVD, Ihd and Stroke in France, by Sex- 2015
Figure 42 Incidence of Cardiovascular Disease in France, by Sex, 2000-2015
Figure 43 Share of Aged Popualtion in the total Population of the U.K., 2005-2045
Figure 44 The Share of Death by Cause in the U.K. Womens, 2014
Figure 45 The Share of Death by Cause in the U.K. Men,2014
Figure 46 Incidence of Cardiovascular Disease in Italy, by Sex, 2000-2015
Figure 47 Incidence of CVD, Ihd and Stroke in Italy, by Sex, 2015
Figure 48 Incidence of CVD, Ihd and Stroke in Spain, by Sex, 2015
Figure 49 Proportion Mortality in Japan by therapeutic Area, 2014
Figure 50 Share of Aging Population in total Chinese Population, 2011-2016 (%)
Figure 51 Major Causes of Death in China, 2014
Figure 52 Mortality Trends in China, 2010-2014
Figure 53 Number of Cases of Coronary Heart Disease (CHD) in India, 2000-2015
Figure 54 Number of People Affected With Dementia, 2015
Figure 55 Number of People With Dementia in Over 60 Years in India, 2015-2050
Figure 56 Principle Causes of Death in Malaysia, 2013-2014
Figure 57 Number of Person Aged 60 Years & Above in Latin America, 2015-2030
Figure 58 Key Growth Strategies Adopted by Key Players -2014-2017
Figure 59 Regulatory Approvals Received by Leading Players, 2014-2017
Figure 60 New Product Launch by Leading Players, 2014-2017
Figure 61 Mergers & Acquisitions by Leading Players, 2014-2017
Figure 62 Medtronic Plc: Financial Overview- 2015-2017
Figure 63 Boston Scientific Corporation: Financial Overview- 2014-2016
Figure 64 LivaNova Plc: Financial Overview- 2015 & 2016
Figure 65 William Demant Holding A/S: Financial Overview- 2014-2016
Figure 66 Cochlear Ltd: Financial Overview- 2015-2017
Figure 67 Sonova Holding Ag: Financial Overview- 2014-2016
Figure 68 Nuvectra Corporation: Financial Overview- 2015 and 2016
Figure 69 Abbott Laboratories: Financial Overview- 2014-2016